IgA nephropathy primary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{IgA nephropathy}} ==References== {{refl..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{IgA nephropathy}} | |||
{{CMG}}; {{AE}} {{SH}} | |||
==Overview== | |||
There are no established measures for the primary prevention of IgA nephropathy. | |||
==Primary Prevention== | |||
*There are no established measures for the primary prevention of IgA nephropathy. | |||
==References== | ==References== | ||
Latest revision as of 14:46, 25 May 2018
|
IgA nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
IgA nephropathy primary prevention On the Web |
|
American Roentgen Ray Society Images of IgA nephropathy primary prevention |
|
Risk calculators and risk factors for IgA nephropathy primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
There are no established measures for the primary prevention of IgA nephropathy.
Primary Prevention
- There are no established measures for the primary prevention of IgA nephropathy.